{"count": 14, "results": [{"_id": "36187122", "pmid": 36187122, "pmcid": "PMC9524196", "title": "Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials", "journal": "Front Endocrinol (Lausanne)", "authors": ["Nabrdalik K", "Skonieczna-Żydecka K", "Irlik K", "Hendel M", "Kwiendacz H", "Łoniewski I", "Januszkiewicz K", "Gumprecht J", "Lip GYH"], "date": "2022-09-14T00:00:00Z", "doi": "10.3389/fendo.2022.975912", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "975912", "score": 50288.19, "text_hl": "There is a higher risk of @<m>DISEASE_Gas_bloat_syndrome</m> @DISEASE_MESH:C535647 @@@bloating@@@ and @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@ with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ immediate-release than with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ extended release formulation.", "citations": {"NLM": "Nabrdalik K, Skonieczna-Żydecka K, Irlik K, Hendel M, Kwiendacz H, Łoniewski I, Januszkiewicz K, Gumprecht J, Lip GYH. Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials Front Endocrinol (Lausanne). 2022;13():975912. PMID: 36187122", "BibTeX": "@article{36187122, title={Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials}, author={Nabrdalik K and Skonieczna-Żydecka K and Irlik K and Hendel M and Kwiendacz H and Łoniewski I and Januszkiewicz K and Gumprecht J and Lip GYH}, journal={Front Endocrinol (Lausanne)}, volume={13}, pages={975912}}"}}, {"_id": "37816179", "pmid": 37816179, "title": "Compounding Metformin for Use in Functional Medicine.", "journal": "Int J Pharm Compd", "authors": ["Desai S", "Thompson T"], "date": "2023-09-01T00:00:00Z", "meta_date_publication": "2023 Sep-Oct", "meta_volume": "27", "meta_issue": "5", "meta_pages": "362-366", "score": 50267.426, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ can cause issues with the gastrointestinal tract and result in @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@, @DISEASE_Abdominal_Pain @DISEASE_MESH:D015746 @@@abdominal pain@@@, @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@, @<m>DISEASE_Gas_bloat_syndrome</m> @DISEASE_MESH:C535647 @@@bloating@@@, or @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@. ", "citations": {"NLM": "Desai S, Thompson T. Compounding Metformin for Use in Functional Medicine. Int J Pharm Compd. 2023 Sep-Oct;27(5):362-366. PMID: 37816179", "BibTeX": "@article{37816179, title={Compounding Metformin for Use in Functional Medicine.}, author={Desai S and Thompson T}, journal={Int J Pharm Compd}, volume={27}, number={5}, pages={362-366}}"}}, {"_id": "35646179", "pmid": 35646179, "pmcid": "PMC9126465", "title": "Barriers against the use of an optimal dose of metformin among patients with T2DM in Thi-Qar province, Iraq", "journal": "J Med Life", "authors": ["Al-Waeli D", "Mohammed A", "Tahir I", "Al-Saeedi A", "Razzaq K", "Abodhurais A"], "date": "2022-04-01T00:00:00Z", "doi": "10.25122/jml-2021-0259", "meta_date_publication": "2022 Apr", "meta_volume": "15", "meta_issue": "4", "meta_pages": "557-562", "score": 50257.324, "text_hl": "...State of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ intake.", "citations": {"NLM": "Al-Waeli D, Mohammed A, Tahir I, Al-Saeedi A, Razzaq K, Abodhurais A. Barriers against the use of an optimal dose of metformin among patients with T2DM in Thi-Qar province, Iraq J Med Life. 2022 Apr;15(4):557-562. PMID: 35646179", "BibTeX": "@article{35646179, title={Barriers against the use of an optimal dose of metformin among patients with T2DM in Thi-Qar province, Iraq}, author={Al-Waeli D and Mohammed A and Tahir I and Al-Saeedi A and Razzaq K and Abodhurais A}, journal={J Med Life}, volume={15}, number={4}, pages={557-562}}"}}, {"_id": "39350158", "pmid": 39350158, "title": "Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies.", "journal": "BMC Endocr Disord", "authors": ["Nabrdalik K", "Hendel M", "Irlik K", "Kwiendacz H", "Łoniewski I", "Bucci T", "Alam U", "Lip GYH", "Gumprecht J", "Skonieczna-Żydecka K"], "date": "2024-09-30T00:00:00Z", "doi": "10.1186/s12902-024-01727-w", "meta_date_publication": "2024 Sep 30", "meta_volume": "24", "meta_issue": "1", "meta_pages": "206", "score": 50256.812, "text_hl": "The incidence of @<m>DISEASE_Gas_bloat_syndrome</m> @DISEASE_MESH:C535647 @@@bloating@@@ (coefficient -4.46; p < 0.001), @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@ (coefficient -1.17; p = 0.0951) @DISEASE_Abdominal_Pain @DISEASE_MESH:D015746 @@@abdominal pain@@@ (coefficient -2.80; p = 0.001), @DISEASE_Constipation @DISEASE_MESH:D003248 @@@constipation@@@ (coefficient -5.78; p = 0.0014) and @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@ (coefficient -2.47; p < 0.001) were lower for extended release (XR) @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ than @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ immediate release (IR) formulation. ", "citations": {"NLM": "Nabrdalik K, Hendel M, Irlik K, Kwiendacz H, Łoniewski I, Bucci T, Alam U, Lip GYH, Gumprecht J, Skonieczna-Żydecka K. Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies. BMC Endocr Disord. 2024 Sep 30;24(1):206. PMID: 39350158", "BibTeX": "@article{39350158, title={Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies.}, author={Nabrdalik K and Hendel M and Irlik K and Kwiendacz H and Łoniewski I and Bucci T and Alam U and Lip GYH and Gumprecht J and Skonieczna-Żydecka K}, journal={BMC Endocr Disord}, volume={24}, number={1}, pages={206}}"}}, {"_id": "32775133", "pmid": 32775133, "pmcid": "PMC7392920", "title": "Bifidobacterium bifidum G9-1 ameliorates soft feces induced by metformin without affecting its antihyperglycemic action", "journal": "Biosci Microbiota Food Health", "authors": ["Makizaki Y", "Maeda A", "Yamamoto M", "Tamura S", "Tanaka Y", "Nakajima S", "Ohno H"], "date": "2020-01-01T00:00:00Z", "doi": "10.12938/bmfh.2019-022", "meta_date_publication": "2020", "meta_volume": "39", "meta_issue": "3", "meta_pages": "145-151", "score": 50256.574, "text_hl": "However, the mechanisms underlying the development of @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@ and @<m>DISEASE_Gas_bloat_syndrome</m> @DISEASE_MESH:C535647 @@@bloating@@@, which are adverse effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, are unclear, and these effects decrease the quality of life of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-receiving @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@. ", "citations": {"NLM": "Makizaki Y, Maeda A, Yamamoto M, Tamura S, Tanaka Y, Nakajima S, Ohno H. Bifidobacterium bifidum G9-1 ameliorates soft feces induced by metformin without affecting its antihyperglycemic action Biosci Microbiota Food Health. 2020;39(3):145-151. PMID: 32775133", "BibTeX": "@article{32775133, title={Bifidobacterium bifidum G9-1 ameliorates soft feces induced by metformin without affecting its antihyperglycemic action}, author={Makizaki Y and Maeda A and Yamamoto M and Tamura S and Tanaka Y and Nakajima S and Ohno H}, journal={Biosci Microbiota Food Health}, volume={39}, number={3}, pages={145-151}}"}}, {"_id": "37871735", "pmid": 37871735, "title": "The co-regulation of the gut microbiome and host genes might play essential roles in metformin gastrointestinal intolerance.", "journal": "Toxicol Appl Pharmacol", "authors": ["Zhang H", "Lai J", "Zhang L", "Zhang W", "Liu X", "Gong Q", "Tian H", "Yang M", "Yang T", "Zhao R", "Li D", "Huang H", "Zhao Y", "Yan S", "Yu M", "Xiyang Y", "Shi L", "Yang L", "Wang L", "Chen W", "Cao X"], "date": "2023-10-21T00:00:00Z", "doi": "10.1016/j.taap.2023.116732", "meta_date_publication": "2023 Oct 21", "meta_volume": "", "meta_issue": "", "meta_pages": "116732", "score": 50250.312, "text_hl": "These samples included 3 fecal and 4 blood from @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-tolerant @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2D@@@ patients before and after @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment (T and Ta), 3 fecal and 5 blood from @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-intolerant @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2D@@@ patients before and after treatment (TS and TSa), and 6 fecal samples from healthy controls. ", "citations": {"NLM": "Zhang H, Lai J, Zhang L, Zhang W, Liu X, Gong Q, Tian H, Yang M, Yang T, Zhao R, Li D, Huang H, Zhao Y, Yan S, Yu M, Xiyang Y, Shi L, Yang L, Wang L, Chen W, Cao X. The co-regulation of the gut microbiome and host genes might play essential roles in metformin gastrointestinal intolerance. Toxicol Appl Pharmacol. 2023 Oct 21;():116732. PMID: 37871735", "BibTeX": "@article{37871735, title={The co-regulation of the gut microbiome and host genes might play essential roles in metformin gastrointestinal intolerance.}, author={Zhang H and Lai J and Zhang L and Zhang W and Liu X and Gong Q and Tian H and Yang M and Yang T and Zhao R and Li D and Huang H and Zhao Y and Yan S and Yu M and Xiyang Y and Shi L and Yang L and Wang L and Chen W and Cao X}, journal={Toxicol Appl Pharmacol}, pages={116732}}"}}, {"_id": "31769886", "pmid": 31769886, "title": "Comparison of gastrointestinal adverse events with different doses of metformin in the treatment of elderly people with type 2 diabetes.", "journal": "J Clin Pharm Ther", "authors": ["Yuxin H", "Cuiping J", "Wen T", "Jieyuzhen Q", "Xiaoming T", "Qin G", "Haidong W", "Jiao S", "Zhijun B"], "date": "2020-06-01T00:00:00Z", "doi": "10.1111/jcpt.13087", "meta_date_publication": "2020 Jun", "meta_volume": "45", "meta_issue": "3", "meta_pages": "470-476", "score": 50247.223, "text_hl": "METHODS: A total of 361 elderly @SPECIES_9606 @@@patients@@@ with newly diagnosed @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ were randomly divided into three groups: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 1000 mg/d (N = 120), @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 1500 mg/d (N = 121) and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 2000 mg/d (N = 120). ", "citations": {"NLM": "Yuxin H, Cuiping J, Wen T, Jieyuzhen Q, Xiaoming T, Qin G, Haidong W, Jiao S, Zhijun B. Comparison of gastrointestinal adverse events with different doses of metformin in the treatment of elderly people with type 2 diabetes. J Clin Pharm Ther. 2020 Jun;45(3):470-476. PMID: 31769886", "BibTeX": "@article{31769886, title={Comparison of gastrointestinal adverse events with different doses of metformin in the treatment of elderly people with type 2 diabetes.}, author={Yuxin H and Cuiping J and Wen T and Jieyuzhen Q and Xiaoming T and Qin G and Haidong W and Jiao S and Zhijun B}, journal={J Clin Pharm Ther}, volume={45}, number={3}, pages={470-476}}"}}, {"_id": "36464072", "pmid": 36464072, "title": "[Cross-Sectional Study on Adverse Effects of Metformin Hydrochloride on 130 Patients Type 2 Diabetic Admitted to Medical Center and Diabetes Home of Sidi Bel-Abbes].", "journal": "Ann Pharm Fr", "authors": ["Sakouhi M", "Matmour D", "Belakhdar K", "Kraroubi A"], "date": "2022-12-02T00:00:00Z", "doi": "10.1016/j.pharma.2022.11.013", "meta_date_publication": "2022 Dec 2", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50246.023, "text_hl": "Five (3.85%) @SPECIES_9606 @@@patients@@@ had a total and lasting intolerance to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MetforminHydrochloride@@@ leading to its discontinuation following persistent @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhoea@@@. ", "citations": {"NLM": "Sakouhi M, Matmour D, Belakhdar K, Kraroubi A. [Cross-Sectional Study on Adverse Effects of Metformin Hydrochloride on 130 Patients Type 2 Diabetic Admitted to Medical Center and Diabetes Home of Sidi Bel-Abbes]. Ann Pharm Fr. 2022 Dec 2;():. PMID: 36464072", "BibTeX": "@article{36464072, title={[Cross-Sectional Study on Adverse Effects of Metformin Hydrochloride on 130 Patients Type 2 Diabetic Admitted to Medical Center and Diabetes Home of Sidi Bel-Abbes].}, author={Sakouhi M and Matmour D and Belakhdar K and Kraroubi A}, journal={Ann Pharm Fr}}"}}, {"_id": "36098362", "pmid": 36098362, "pmcid": "PMC9797791", "title": "Metformin with Versus without Concomitant Probiotic Therapy in Newly Diagnosed Patients with Type 2 Diabetes or Prediabetes: A Comparative Analysis in Relation to Glycemic Control, Gastrointestinal Side Effects, and Treatment Compliance", "journal": "Turk J Gastroenterol", "authors": ["Şahin K", "Şahintürk Y", "Köker G", "Özçelik Köker G", "Bostan F", "Kök M", "Uyar S", "Çekin AH"], "date": "2022-11-01T00:00:00Z", "doi": "10.5152/tjg.2022.211063", "meta_date_publication": "2022 Nov", "meta_volume": "33", "meta_issue": "11", "meta_pages": "925-933", "score": 50243.54, "text_hl": "@DISEASE_Signs_and_Symptoms_Digestive @DISEASE_MESH:D012817 @@@Gastrointestinal intolerance symptoms@@@, @<m>DISEASE_Gas_bloat_syndrome</m> @DISEASE_MESH:C535647 @@@bloating@@@, in particular, were the leading cause of treatment non-compliance in our @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-treated @SPECIES_9606 @@@patients@@@, especially after 15 days of treatment with the introduction of higher doses of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Şahin K, Şahintürk Y, Köker G, Özçelik Köker G, Bostan F, Kök M, Uyar S, Çekin AH. Metformin with Versus without Concomitant Probiotic Therapy in Newly Diagnosed Patients with Type 2 Diabetes or Prediabetes: A Comparative Analysis in Relation to Glycemic Control, Gastrointestinal Side Effects, and Treatment Compliance Turk J Gastroenterol. 2022 Nov;33(11):925-933. PMID: 36098362", "BibTeX": "@article{36098362, title={Metformin with Versus without Concomitant Probiotic Therapy in Newly Diagnosed Patients with Type 2 Diabetes or Prediabetes: A Comparative Analysis in Relation to Glycemic Control, Gastrointestinal Side Effects, and Treatment Compliance}, author={Şahin K and Şahintürk Y and Köker G and Özçelik Köker G and Bostan F and Kök M and Uyar S and Çekin AH}, journal={Turk J Gastroenterol}, volume={33}, number={11}, pages={925-933}}"}}, {"_id": "39455403", "pmid": 39455403, "title": "Gastrointestinal adverse effects of old and new antidiabetics: How do we deal with them in real life?", "journal": "Rev Gastroenterol Mex (Engl Ed)", "authors": ["Barrientos-Ávalos JR", "Morel-Cerda EC", "Félix-Téllez FA", "Vidrio-Huerta BE", "Aceves-Ayala AR", "Flores-Rendón ÁR", "Velarde-Ruiz Velasco JA"], "date": "2024-10-24T00:00:00Z", "doi": "10.1016/j.rgmxen.2024.10.008", "meta_date_publication": "2024 Oct 24", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50238.03, "text_hl": "The medications most frequently associated with said adverse effects are @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_Acarbose @CHEMICAL_MESH:D020909 @@@acarbose@@@, and @GENE_GLP1R @GENE_2740 @@@GLP-1@@@ agonists. ", "citations": {"NLM": "Barrientos-Ávalos JR, Morel-Cerda EC, Félix-Téllez FA, Vidrio-Huerta BE, Aceves-Ayala AR, Flores-Rendón ÁR, Velarde-Ruiz Velasco JA. Gastrointestinal adverse effects of old and new antidiabetics: How do we deal with them in real life? Rev Gastroenterol Mex (Engl Ed). 2024 Oct 24;():. PMID: 39455403", "BibTeX": "@article{39455403, title={Gastrointestinal adverse effects of old and new antidiabetics: How do we deal with them in real life?}, author={Barrientos-Ávalos JR and Morel-Cerda EC and Félix-Téllez FA and Vidrio-Huerta BE and Aceves-Ayala AR and Flores-Rendón ÁR and Velarde-Ruiz Velasco JA}, journal={Rev Gastroenterol Mex (Engl Ed)}}"}}]}